全球动物内分泌学市场

预计到 2030 年全球兽医内分泌市场规模将达到 4.233 亿美元

全球兽医内分泌市场规模预计在2024年为3.153亿美元，预计到2030年将达到4.233亿美元，2024年至2030年的复合年增长率为5.0%。犬科动物是本报告分析的细分市场之一，预计其复合年增长率为5.5%，到分析期结束时将达到2.529亿美元。猫科动物细分市场在分析期间内的复合年增长率估计为3.9%。

美国市场规模估计为 8,590 万美元，中国市场预计复合年增长率为 8.1%

美国兽医内分泌市场规模预计在2024年达到8,590万美元。作为世界第二大经济体，中国预计2030年市场规模将达到8,430万美元，在2024-2030年的分析期间内，复合年增长率为8.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.4%和5.0%。在欧洲，预计德国市场的复合年增长率为3.2%。

全球动物内分泌市场－主要趋势与驱动因素摘要

为什么兽医内分泌学在动物保健中变得越来越重要？

兽医内分泌学是兽医学的一个分支学科，主要研究动物体内荷尔蒙相关的疾病。由于伴侣动物和牲畜内分泌失调的发生率不断上升，兽医内分泌学的重要性也日益凸显。糖尿病、甲状腺机能低下症、甲状腺功能亢进症、库欣氏症和爱迪生氏症疾病在宠物中越来越常见，尤其是在兽医诊断技术的进步使得早期发现成为可能之后。遗传易感性、肥胖、老龄化和环境压力等因素导致动物内分泌失调发病率上升。随着宠物饲主越来越关注宠物的健康，对内分泌学特效治疗的需求也日益增长，包括荷尔蒙补充疗法、胰岛素治疗和饮食管理策略。此外，由于兽医照护水准的提高，伴侣动物的寿命也随之延长，与老龄化相关的内分泌失调的发生率也在上升，因此需要製定长期的管理方案。对于牲畜而言，荷尔蒙失衡会影响繁殖率、生长发育和产乳量，并可能造成严重的经济后果。随着兽医学领域日益专业化，动物内分泌学已成为关注的重点领域，推动了对先进诊断工具、治疗方法和荷尔蒙健康研究的需求。

动物内分泌学的最新创新是什么？

兽医内分泌学领域正在经历一场技术变革，创新的诊断和治疗方法提高了荷尔蒙相关疾病管理的准确性和有效性。其中最重要的进展之一是照护现场诊断工具的开发，使兽医能够透过血液检测快速评估荷尔蒙失衡，从而缩短诊断时间并实现及时介入。持续血糖监测 (CGM) 系统最初是为人类糖尿病管理而开发的，现在已广泛应用于糖尿病宠物，即时追踪血糖浓度并优化胰岛素治疗。基因诊断方法的兴起也提高了检测与基因突变相关的内分泌疾病的能力，尤其是在某些容易罹患甲状腺和肾上腺功能障碍的犬猫品种中。此外，长效胰岛素类似物和缓释性激素植入等新剂型正在提高内分泌治疗的有效性和便利性。研究人员也正在探索再生医学，包括干细胞疗法，作为未来治疗方法内分泌功能障碍（尤其是胰岛素依赖型糖尿病和肾上腺功能障碍）的途径。人工智慧与兽医内分泌学的融合，进一步革新了疾病管理。人工智慧演算法能够帮助兽医诊断复杂的荷尔蒙失衡问题，并根据既往病史数据预测治疗结果。此类技术进步显着提升了动物内分泌失调的管理能力，确保动物获得更佳的长期健康结果。

兽医内分泌疾病管理面临哪些挑战？

儘管兽医内分泌学取得了进展，但在内分泌疾病的诊断和治疗方面仍然存在许多挑战。一个主要困难是荷尔蒙失衡的诊断复杂性，因为许多内分泌疾病的症状特异性，且与其他疾病重迭。这常常导致诊断延误或误诊，尤其是在早期阶段。另一个主要挑战是，许多内分泌疾病，例如糖尿病和甲状腺机能低下症，需要终身管理，需要持续监测并严格遵守药物。长期治疗的费用，包括药物、诊断检测和后续观察，给宠物饲主带来了沉重的负担，并导致依从性和治疗中断问题。在畜牧业中，荷尔蒙疗法及其在食品中的潜在残留引发了人们对食品安全和法规遵从性的担忧，导致对食用动物激素使用的严格监管。兽医内分泌学专家的匮乏也构成了障碍，因为普通兽医并不总是能够获得高级内分泌学培训或诊断资源。此外，围绕着动物荷尔蒙疗法）的伦理影响的持续争论，也为该领域增添了新的复杂性。克服这些挑战需要持续的研究、改进的诊断方法，以及提高兽医和动物饲主对动物内分泌健康重要性的认识。

兽医内分泌市场的主要成长动力是什么？

兽医内分泌市场的成长受到多种因素的推动，包括诊断技术的进步、宠物寿命的延长以及人们对内分泌健康的认识不断提高。其中一个关键因素是伴侣动物内分泌疾病的盛行率不断上升，这需要更专业的兽医照护。随着越来越多的饲主为他们的宠物寻求全面的医疗保健解决方案，对内分泌相关的诊断、药物和专业兽医服务的需求也日益增长。缓释性荷尔蒙植入和精准医疗等新型治疗方法的发展也推动了市场的扩张。兽医远端医疗日益增长的影响力在扩大内分泌咨询服务覆盖范围方面发挥关键作用，尤其是在偏远和服务不足的地区。此外，在「同一个健康」框架下，人医与兽医之间日益密切的合作正在推动跨学科研究，从而加速内分泌疾病管理的进步。扩大宠物保险对慢性疾病（包括内分泌疾病）的覆盖范围，进一步鼓励宠物饲主投资长期治疗方案。此外，畜牧业对提高生产力解决方案的需求，也推动了基于荷尔蒙的治疗方法的研究，旨在优化繁殖效率和生长率。持续投入研发和技术，为动物内分泌相关疾病提供更精准、更有效的治疗方案，预计将推动兽医内分泌学市场的持续成长。

部分

依动物类型（狗、猫、其他动物）；依用途（胰臟疾病、其他疾病）；依给药途径（口服、其他途径）

分析的公司范例

• Alltech
• Bayer Animal Health
• Bimeda
• Boehringer Ingelheim
• Braasch Biotech
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Elanco Animal Health
• Heska Corporation
• IDEXX Laboratories
• Jurox
• Kyoritsu Seiyaku Corporation
• Lohmann Animal Health
• Merck & Co., Inc.
• Neogen Corporation
• Norbrook Laboratories
• Phibro Animal Health Corporation
• Royal DSM
• SeQuent Scientific Limited
• Vetoquinol

人工智慧集成

全球产业分析师利用有效的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章 分析方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Veterinary Endocrinology Market to Reach US$423.3 Million by 2030

The global market for Veterinary Endocrinology estimated at US$315.3 Million in the year 2024, is expected to reach US$423.3 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Dogs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$252.9 Million by the end of the analysis period. Growth in the Cats segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.9 Million While China is Forecast to Grow at 8.1% CAGR

The Veterinary Endocrinology market in the U.S. is estimated at US$85.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$84.3 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Veterinary Endocrinology Market - Key Trends & Drivers Summarized

Why Is Veterinary Endocrinology Gaining Importance in Animal Healthcare?

Veterinary endocrinology, the branch of veterinary medicine that deals with hormone-related disorders in animals, has been gaining increasing importance due to the rising prevalence of endocrine disorders in companion and livestock animals. Conditions such as diabetes mellitus, hypothyroidism, hyperthyroidism, Cushing’s disease, and Addison’s disease are becoming more commonly diagnosed in pets, particularly as advancements in veterinary diagnostics improve early detection. Factors such as genetic predisposition, obesity, aging, and environmental stressors contribute to the rising incidence of endocrine disorders in animals. As pet owners become more invested in their animals’ health, there is a growing demand for specialized endocrinology treatments, including hormone replacement therapy, insulin therapy, and dietary management strategies. Additionally, the increasing lifespan of companion animals due to better veterinary care has led to a higher occurrence of age-related endocrine disorders, necessitating long-term management solutions. In livestock, hormonal imbalances can have significant economic consequences, affecting reproduction rates, growth, and milk production, making veterinary endocrinology crucial for ensuring optimal farm productivity. With the veterinary field becoming more specialized, endocrinology is emerging as a key focus area, driving demand for advanced diagnostic tools, treatment modalities, and research in hormonal health.

What Are the Latest Innovations in Veterinary Endocrinology?

The field of veterinary endocrinology is undergoing a technological transformation, with innovative diagnostic and treatment approaches improving the accuracy and effectiveness of hormone-related disease management. One of the most significant advancements is the development of point-of-care diagnostic tools that allow veterinarians to quickly assess hormonal imbalances through blood tests, reducing the time needed for diagnosis and enabling immediate intervention. Continuous glucose monitoring (CGM) systems, initially developed for human diabetes management, are now widely used in diabetic pets, providing real-time glucose level tracking and optimizing insulin therapy. The rise of gene-based diagnostics is also enhancing the ability to detect endocrine disorders linked to genetic mutations, particularly in specific dog and cat breeds prone to thyroid or adrenal gland dysfunction. Additionally, novel drug formulations, such as long-acting insulin analogs and slow-release hormonal implants, are improving the effectiveness and convenience of endocrine treatments. Researchers are also exploring regenerative medicine, including stem cell therapy, as a potential future treatment for endocrine dysfunctions, particularly in insulin-dependent diabetes and adrenal gland disorders. The integration of artificial intelligence into veterinary endocrinology is further revolutionizing disease management, with AI-powered algorithms assisting veterinarians in diagnosing complex hormonal imbalances and predicting treatment outcomes based on historical patient data. These technological advancements are significantly enhancing the ability to manage endocrine disorders in animals, ensuring better long-term health outcomes.

What Are the Challenges in Managing Endocrine Disorders in Veterinary Medicine?

Despite the progress in veterinary endocrinology, several challenges persist in the diagnosis and management of endocrine disorders. One of the primary difficulties is the complexity of diagnosing hormonal imbalances, as many endocrine disorders present with non-specific symptoms that overlap with other medical conditions. This often results in delayed or misdiagnosed cases, particularly in early disease stages. Another major challenge is the lifelong management required for many endocrine disorders, such as diabetes mellitus and hypothyroidism, which necessitate continuous monitoring and strict medication adherence. The cost of long-term treatment, including medications, diagnostic testing, and follow-up consultations, can be a significant burden for pet owners, leading to issues of compliance and treatment discontinuation. In the livestock industry, hormonal treatments and their potential residues in food products raise concerns about food safety and regulatory compliance, leading to strict regulations on hormone usage in food-producing animals. The limited availability of veterinary specialists in endocrinology also presents a barrier, as general veterinarians may not always have access to advanced endocrinology training and diagnostic resources. Furthermore, ongoing debates surrounding the ethical implications of hormone therapy in animals, particularly in reproductive management and growth enhancement, add another layer of complexity to the field. Overcoming these challenges requires continuous research, improved diagnostic methodologies, and increased awareness among both veterinarians and pet owners about the importance of endocrine health in animals.

What Are the Key Growth Drivers of the Veterinary Endocrinology Market?

The growth in the veterinary endocrinology market is driven by several factors, including advancements in diagnostic technology, increasing pet lifespan, and rising awareness about endocrine health. One of the major drivers is the increasing prevalence of endocrine disorders in companion animals, necessitating more specialized veterinary care. As more pet owners seek comprehensive healthcare solutions for their animals, there is a growing demand for endocrine-related diagnostics, medications, and specialized veterinary services. The development of novel treatment modalities, such as sustained-release hormonal implants and precision medicine approaches, is also fueling market expansion. The growing influence of veterinary telemedicine is playing a significant role in expanding access to endocrinology consultations, particularly in remote and underserved regions. Additionally, the increasing collaboration between human and veterinary medicine under the One Health framework is leading to cross-disciplinary research that accelerates advancements in endocrine disease management. The expansion of pet insurance coverage for chronic diseases, including endocrine disorders, is further encouraging pet owners to invest in long-term treatment solutions. Furthermore, the demand for productivity-enhancing solutions in livestock farming is propelling research into hormone-based treatments that optimize reproductive efficiency and growth rates. With continued investment in research and technology, the veterinary endocrinology market is expected to see sustained growth, offering more precise and effective treatment options for endocrine-related conditions in animals.

SCOPE OF STUDY:

The report analyzes the Veterinary Endocrinology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Dogs, Cats, Other Animals); Application (Pancreatic Disorders, Other Disorders); Administration Route (Oral, Other Routes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

• Alltech
• Bayer Animal Health
• Bimeda
• Boehringer Ingelheim
• Braasch Biotech
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Elanco Animal Health
• Heska Corporation
• IDEXX Laboratories
• Jurox
• Kyoritsu Seiyaku Corporation
• Lohmann Animal Health
• Merck & Co., Inc.
• Neogen Corporation
• Norbrook Laboratories
• Phibro Animal Health Corporation
• Royal DSM
• SeQuent Scientific Limited
• Vetoquinol

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Veterinary Endocrinology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Diabetes Mellitus in Companion Animals Throws the Spotlight On Hormonal Disorder Management
  • Growth in Aging Pet Population Drives Demand for Chronic Endocrine Disease Monitoring and Care
  • Increased Awareness Among Pet Owners Spurs Growth in Veterinary Diagnostic Endocrinology Services
  • Expansion of Veterinary Internal Medicine Capabilities Strengthens Business Case for Specialized Endocrinology Clinics
  • Advancements in Hormone Assay Technologies Expand Addressable Market Opportunity for Precision Diagnostics
  • Development of Point-of-Care Testing Devices Generates Accelerated Demand for In-Clinic Hormonal Testing
  • Integration of Endocrine Panels in Routine Wellness Programs Drives Adoption of Preventive Endocrinology
  • Rising Incidence of Adrenal and Thyroid Disorders in Small Animals Spurs Growth in Targeted Therapies
  • Advances in Companion Animal Nutrition Strengthen the Role of Diet in Endocrine Disease Management
  • Emergence of Continuous Glucose Monitoring Technologies Drives Innovation in Feline and Canine Diabetes Care
  • Growth in Veterinary Specialty Hospitals Expands Access to Advanced Endocrine Treatment Protocols
  • Increasing Pet Insurance Penetration Drives Adoption of Costly Endocrine Diagnostics and Therapies
  • R&D in Recombinant Hormone Therapies Expands Therapeutic Options for Endocrine Deficiencies
  • Demand for Integrated Endocrinology Modules in Veterinary EHR Platforms Enhances Clinical Workflow Efficiency
  • Growth of Veterinary Teleconsultation Services Spurs Remote Management of Endocrine Disorders
  • Regulatory Focus on Quality and Standardization of Hormonal Assays Strengthens Market Credibility
  • Rise in Cross-Species Endocrinology Research Enhances Drug Development and Translational Medicine
  • Veterinary Academic Programs Emphasize Endocrinology Training to Address Growing Clinical Demand
  • Increase in Exotic Animal Ownership Creates New Opportunities in Non-Traditional Endocrinology Services
  • Expansion of Clinical Trials and Evidence-Based Protocols Supports Evidence-Driven Endocrine Treatments
  • Innovation in Long-Acting Hormonal Implants and Injectable Therapies Drives Convenience-Based Adoption
  • Globalization of Veterinary Services and Cross-Border Pet Travel Raises Focus on Endocrine Disease Screening and Continuity of Care
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Veterinary Endocrinology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Veterinary Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Veterinary Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Dogs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Cats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pancreatic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pancreatic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pancreatic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: USA 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: Canada 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• JAPAN
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Japan 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• CHINA
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: China 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• EUROPE
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Veterinary Endocrinology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Veterinary Endocrinology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Europe 15-Year Perspective for Veterinary Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• FRANCE
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: France 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• GERMANY
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: UK 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Spain 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Russia 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Endocrinology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Veterinary Endocrinology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 15-Year Perspective for Veterinary Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Australia 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• INDIA
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: India 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: South Korea 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Veterinary Endocrinology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Veterinary Endocrinology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Latin America 15-Year Perspective for Veterinary Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Argentina 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Brazil 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Mexico 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Veterinary Endocrinology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Veterinary Endocrinology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Middle East 15-Year Perspective for Veterinary Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Iran 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Israel 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: UAE 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030
• AFRICA
  • Veterinary Endocrinology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Veterinary Endocrinology by Animal Type - Dogs, Cats and Other Animals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Africa 15-Year Perspective for Veterinary Endocrinology by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animals for the Years 2015, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Veterinary Endocrinology by Application - Pancreatic Disorders and Other Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Veterinary Endocrinology by Application - Percentage Breakdown of Value Sales for Pancreatic Disorders and Other Disorders for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Veterinary Endocrinology by Administration Route - Oral and Other Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Veterinary Endocrinology by Administration Route - Oral and Other Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Veterinary Endocrinology by Administration Route - Percentage Breakdown of Value Sales for Oral and Other Routes for the Years 2015, 2025 & 2030

IV. COMPETITION